caprylohydroxamic acid,
octanohydroxamic acid,
octanohydroxamic acid, 3H-labeled cpd,
Taselin,
N-Hydroxyoctanamide,
OCTANOHYDROXAMIC ACID,
7377-03-9,
Caprylohydroxamic acid,
Octanamide, N-hydroxy-,
Taselin,
Octanoylhydroxamic acid,
Octanohydroxamsaeure,
octanehydroxamic acid,
CAPRYLOHYDROXAMATE,
UNII-UPY805K99W,
UPY805K99W,
EINECS 230-936-7,
BRN 1703666,
Carpylohydroxamic acid,
octanoic acid hydroxyamide,
ACMC-2097kz,
KSC377K4N,
SCHEMBL572646,
AC1L2N16,
N-Hydroxyoctanamide, AldrichCPR,
DTXSID8074609,
Octanamide, N-hydroxy- (9CI),
CTK2H7546,
RGUVUPQQFXCJFC-UHFFFAOYSA-,
RGUVUPQQFXCJFC-UHFFFAOYSA-N,
KS-00000B9A,
ANW-14097,
MFCD00143918,
RW2979,
ZINC95740180,
AKOS009158157,
CS-W001857,
MCULE-2604662374,
RP22289,
RTR-023911,
TRA0073561,
AK-43792,
AS-20087,
LS-97939,
SY020160,
AB1004644,
DB-029564,
ST2413639,
TR-023911,
4CH-006391,
C1232,
FT-0084653,
FT-0660306,
FT-0695202,
ST50997784,
Z5082,
M-7695,
MFCD00143918 (97+%),
J-523591,
InChI=1/C8H17NO2/c1-2-3-4-5-6-7-8(10)9-11/h11H,2-7H2,1H3,(H,9,10),
Octanohydroxamic acid (6CI,7CI,8CI); Caprylohydroxamic acid; N-Hydroxyoctanamide; Octanoylhydroxamic acid; Taselin,
N-Hydroxyoctamide,
Caprylhydroxamic acid,
C8H17NO2,
CID23846,
ACN-040689,
3-02-00-00799 (Beilstein Handbook Reference),